WD-40 (WDFC) Q2 2026 earnings review

FX Masks Core Sluggishness Despite Margin Resilience

WD-40 Company reported an optical blowout with 11% YoY revenue growth in Q2. However, removing a massive $9.3M foreign currency tailwind reveals constant-currency growth of just 4%—falling short of the company's 5-9% pro forma guidance range. Profitability remains the bright spot: Gross margins expanded to 55.6%, cementing the structural improvements made over the past year. While GAAP EPS fell 32% due to an $11.9M tax benefit in the prior year, adjusted diluted EPS grew a healthy 14% to $1.32. The impending Americas homecare divestiture hangs over the narrative, but management confidently reaffirmed their full-year outlook.

🐂 Bull Case

Margin Targets Achieved Early and Held

Gross margin expanded 100 bps YoY to 55.6%. Supply chain initiatives are structurally improving profitability, proving that last year's margin recovery was not a temporary blip.

Asia-Pacific Destocking Concluded

After struggling with distributor inventory normalization in recent quarters, Asia-Pacific sales surged 19% YoY, indicating that the channel is clear and baseline demand is flowing through.

🐻 Bear Case

Constant Currency Deceleration

Stripping out the favorable FX impact, total net sales grew only 4%. EIMEA actually declined 3% on a constant currency basis, suggesting European demand is weaker than the reported 9% growth implies.

Expense Bloat Squeezing Margins

SG&A rose 12% and Ad & Promo spiked 19% YoY. Operating expenses are vastly outpacing the 4% constant currency top-line growth, damaging the operating leverage narrative.

⚖️ Verdict: ⚪

Neutral. The structural gross margin improvements are excellent and the Asia-Pacific rebound is encouraging. However, the heavy reliance on FX tailwinds to hit headline growth numbers, combined with bloated SG&A spending, warrants caution.

Key Themes

DRIVER🟢

Asia-Pacific Distributor Rebound

Reversing the 10% YoY decline seen in Q1, Asia-Pacific posted a 19% YoY surge to $25.0M. Management cited a strong rebound following the normalization of distributor inventory levels, combined with successful promotional programs in China (+18%). This signals the end of a painful destocking phase.

DRIVER🟢

WD-40 Specialist Premiumization

The Specialist product line continues accelerating, soaring 20% YoY in Q2 to $22.3M. China was a major standout (+55% for the region), driven by specific industrial channel and online distribution wins. This segment is accretive to margins and proves that WD-40's product innovation is successfully penetrating professional use cases.

DRIVERNEW🟢

Aggressive Capital Returns

Management has shifted from a passive to an active stance on buybacks. They repurchased $8.0M in shares in Q2 (up from $3.6M in Q1) and explicitly stated they intend to accelerate activity to fully exhaust the remaining $13.8M of their authorization before the end of FY26.

CONCERN🔴

SG&A Outpacing Core Growth

Despite management's positive narrative around operating leverage, the data contradicts this. Constant currency sales grew just 4%, but SG&A exploded by 12% ($54.8M) and Advertising & Promotion jumped 19% ($8.8M). The company must prove these investments will generate future top-line acceleration, or operating margins will eventually compress.

CONCERN🔴

EIMEA Constant Currency Contraction

Optical EIMEA revenue grew 9%, but translation benefits completely masked a core decline. On a constant currency basis, EIMEA actually fell 3% to $57.5M. Volume growth in direct markets was entirely offset by volume declines in EIMEA distributor markets, indicating localized macro weakness.

CONCERN

Macro: Geopolitical & Geoeconomic Uncertainty

Management explicitly cited the need for robust US promotional activity and improving momentum in EIMEA/APAC to 'mitigate uncertainty related to any global economic and geopolitical conditions.' This suggests internal models are baking in potential macro headwinds for the back half of the year.

THEME

HCCP Americas Divestiture Drag

The exit from Homecare and Cleaning Products (HCCP) is structurally correct for margins, but the pending Americas sale creates guidance uncertainty. HCCP sales dropped 29% in Q2 due to the UK divestiture. If the Americas divestiture fails, FY26 guidance would mechanically increase by $12.5M in sales and $0.20 in EPS—meaning current 'pro forma' guidance effectively punishes headline numbers until the deal closes.

Other KPIs

Gross Margin55.6%

Stable. Up 100 basis points from 54.6% in 25Q2, holding comfortably inside the guided 55.5%-56.5% range. Supply chain optimization is currently providing a buffer, giving management breathing room to implement pricing actions if input inflation returns.

Operating Cash Flow (6 Months)$24.3 million

Stable. Slightly higher than the $22.9M generated in the first half of FY25. Working capital remains a slight drag, with inventory climbing to $85.5M (up from $79.9M at FY25 year-end), likely reflecting buffer stock for supply chain mitigation.

Guidance

FY26 Pro Forma Net Sales$630 - $655 million

Stable. This implies 5% to 9% growth versus 2025 pro forma results. Given that Q2 constant currency growth was only 4%, hitting the midpoint of this guidance will require an acceleration in core volumes in the second half of the year.

FY26 Diluted EPS$5.75 - $6.15

Stable. Reaffirmed range representing an anticipated growth of 5% to 12% versus 2025 pro forma results. With adjusted Q2 EPS up 14%, WDFC is currently tracking toward the high end of this range.

FY26 Gross Margin55.5% - 56.5%

Stable. Reaffirmed target. Management explicitly stated that recent supply chain initiatives are supporting near-term gross margin, signaling high confidence in maintaining this historically elevated profitability tier.

Key Questions

EIMEA Constant Currency Weakness

EIMEA contracted 3% on a constant currency basis this quarter due to weakness in distributor markets. Which specific countries are driving this decline, and is this a macro issue or a shift in distributor inventory strategies?

SG&A and Ad Spend Justification

Ad and Promo expenses grew 19% and SG&A grew 12%—both vastly exceeding constant currency sales growth of 4%. Are these elevated spend levels the 'new normal' required to generate mid-single-digit volume growth, or will these expenses moderate in H2?

HCCP Divestiture Timeline

The UK homecare divestiture was completed in Q4 2025, but the Americas portfolio is still pending. What are the primary hurdles delaying the Americas transaction, and what is the hard deadline before WDFC pivots back to operating it internally?